OpenAI advances recursive AI; new startup pursues self-improving systems amid leaked experimental model names.

In the latest close session, Recursion Pharmaceuticals (RXRX) was down 1.45% at $3.41. This move lagged the S&P 500's daily gain of 0.29%. Elsewhere, the Dow saw a downswing of 0.31%, while the ...

A ripple tells you something happened, but not exactly what. That is the core problem behind a hard class of equations that ...

Penn Engineers have developed a new way to use AI to solve inverse partial differential equations (PDEs), a particularly ...

Recursion Pharmaceuticals (RXRX) ended the recent trading session at $3.30, demonstrating a -3.23% change from the preceding day's closing price. This change lagged the S&P 500's 0.04% loss on the day ...

Former employees at AI giants are raising hundreds of millions of dollars from investors months on from launching.

Arcjet thinks it has the answer. The company this week introduced Guards, a service designed to enforce security inside AI ...

Legacy IAM can't govern autonomous AI agents that spin up, execute and terminate in seconds. New identity patterns are now emerging. The post Why Traditional IAM Is No Match for Agentic AI appeared ...

We are preserving culture, as it gives us identity, and stories to tell. We have systems that store culture. Systems ...

There is a reliable tell for when a market has crossed from enthusiasm into irrational exuberance: The cost of capital ...